Lung Cancer Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are currently enrolled, or will be enrolled in the future, in one of the LungMate series of lung cancer clinical trials (LungMate-001 through LungMate-015, as listed by the trial organisers)
- People aged 18 years or older
- People who have had their lung cancer confirmed by laboratory tissue testing as either non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC)
- People who have provided written consent to participate
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who did not pass the screening criteria for a LungMate trial, or who previously dropped out of one of these trials
- People with any condition that, in the treating doctor's judgement, would make participation unsafe or make it difficult to follow the trial's requirements
- People who have had a different type of cancer in the five years before the trial — with the exception of certain early-stage or fully treated cancers, specifically cervical carcinoma in situ, basal cell skin cancer that has been cured, or certain early-stage bladder tumours (confirm with trial site)
- People who are currently carrying active hepatitis B, hepatitis C, or HIV
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Peng Zhang, PhD, Shanghai Pulmonary Hospital, Shanghai, China
Phone: 021-65115006
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Intratumour heterogeneity index
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.